Bring next-generation
therapies to underserved patients
we are committed to providing high-quality and affordable innovative therapies for patients. With full-chain capabilities from novel discovery through clinical development, manufacturing, and commercialization, we are driven by innovation to make a lasting impact.we are committed to providing high-quality and affordable innovative therapies for patients. With full-chain capabilities from novel discovery through clinical development, manufacturing, and commercialization, we are driven by innovation to make a lasting impact.
A Diversified and Globally Competitive Pipeline
We focus on autoimmune diseases and oncology, building a world-class pipeline of innovative biologic therapies and advancing multiple candidates through efficient clinical development.
Autoimmune and
chronic diseases
chronic diseases
Oncology
50+
In R&D
10+
In Clinical Trials
5
Bispecific Antibody
2
ADC
Efficient in-house R&D capability and
fully-integrated R&D platform
Meet the cGMP standards of NMPA, FDA, and EMA
Powered by efficient fully integrated in-house R&D capabilities, Keymed has established an industry-leading innovation engine to accelerate the development of novel treatments.